Crispr Therapeutics Ag (CRSP)

Free Cash Flow Growth

-14.81%

TTM · Period ending:

CRSP logo

CRSP Free Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-14.81%
CRSP TTM Free Cash Flow YoY % (-200.09% → -14.81%)
High-resolution chart · PNG

CRSP free cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crispr Therapeutics Ag Free Cash Flow Growth — Trailing twelve months (TTM)
Period endingFree Cash Flow Growth
-14.8145%
-30.3116%
-139.107%
-58.5468%
-158.2984%
-84.8404%
46.3859%
34.644%
65.1636%
55.7743%
49.3657%
42.4823%
29.8503%
-190.8861%
-216.5466%
-209.3743%
-202.7045%
233.9925%
278.1162%
378.7173%
1,007.7846%
-879.7206%
-613.5199%
-1,016.9039%
133.9774%
132.8856%
150.4919%
121.4874%
-60.9615%
-61.9767%
-27.0835%
-2.641%
-7.0501%
0.4279%
-33.5785%
-376.6961%
-305.1587%
-250.7267%
-200.0892%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.